average tirzepatide dose When Should You Go Up on Tirzepatide: Escalation Guide Do GLP-1 drugs work better

Second, sarcopenia risk increases

thyroid cancer or hyperthyroidism, gastroparesis, pancreatic cancer or pancreatitis, MEN2 syndrome, or inflammatory bowel disease)

It is currently in late-stage clinical trials (phase 3) and has not received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)

Similarly, those with allergies to GLP-1 receptor agonists should approach treatment with caution, under professional guidance available at Klinic

Regular follow-up visits allow the care team to evaluate results, address concerns, and make adjustments to support safe and sustainable weight loss outcomes